MedTrace Logo

Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)

NCT01888185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 290

Last updated 2020-01-03

No results posted yet for this study

Summary

This study is designed to determine if magnetic resonance imaging (MRI) measures can be used to diagnose and monitor the progression of Parkinson's disease (PD) while distinguishing between PD and parkinsonisms \[conditions that are PD look-a-like diseases such as progressive supranuclear palsy (PSP) or multiple system atrophy (MSA)\] when combined with changes in certain proteins in body fluids that are related to iron (Fe).

Conditions

  • Parkinson's Disease (PD)
  • Parkinsonism
  • Progressive Supranuclear Palsy (PSP)
  • Multiple System Atrophy (MSA)

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01888185 on ClinicalTrials.gov